Novavax Inc <a href="https://www.reuters.com/markets/companies/NVAX.O" target="_blank">(NVAX.O)</a> said on Tuesday its updated protein-based COVID-19 vaccine generated an immune response against emerging forms of coronavirus such as the "Eris" subvariant in …